RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jason Meggs has joined Worldwide Clinical Trials, a global contract research organization (CRO), as Chief Financial Officer (CFO) to lead its finance, accounting, and legal functions. This strategic addition positions Worldwide to drive continued above market growth, focus on innovative clinical trial solutions, and respond to rising demand in key therapeutic areas such as neuroscience, oncology, rare disease, and cardiometabolic and inflammatory disease.
Meggs brings more than 25 years of leadership experience in the life sciences industry, including recent roles as CFO at TriNetX and Syneos Health. Prior, he held various leadership positions at Quintiles (now IQVIA) and INC Research after starting his career as a financial auditor with Arthur Andersen and Deloitte. With his extensive financial expertise and strategic vision, he will be instrumental in advancing Worldwide’s mission to deliver cutting-edge clinical research services and empowering sponsors in the development of transformative, life-changing therapies.
"Jason’s deep industry knowledge and strong financial acumen, spanning clinical development and commercialization services in the life sciences industry, will be instrumental in driving our continued growth and success as we partner with our customers to deliver life-changing medications to patients around the world," said Peter Benton, CEO of Worldwide Clinical Trials. "We’re excited to welcome Jason to the Worldwide team – his expertise will enhance value and accelerate our impact.”
Meggs will oversee Worldwide’s financial and legal strategy, including accounting, financial planning and analysis, operational finance, tax, treasury, and customer contract negotiation and management – helping the organization drive operational efficiency and deliver strong results for its stakeholders.
“I am excited to join Worldwide at such a pivotal moment in the company’s growth trajectory,” said Meggs. “Worldwide’s commitment to partnering with customers to deliver life-changing medications for patients aligns perfectly with my experience, and I am committed to driving innovation, optimizing operations, and delivering exceptional results for our employees and customers.”
Meggs earned a Bachelor of Business Administration, Accounting from Western Carolina University and is a licensed Certified Public Accountant in North Carolina.
About Worldwide Clinical Trials:
Worldwide Clinical Trials (Worldwide) is a full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality. Worldwide’s capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by an accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program. Worldwide is therapeutically focused on neuroscience, oncology, rare disease, and cardiometabolic and inflammatory disease. Its global footprint spans over 60 countries with more than 3,600 team members. For more information, visit www.worldwide.com.
